Katia Fettucciari

Prof. Dr. Katia Fettucciari

Medicine and Surgery, University of Perugia, Perugia, Umbria, Italy
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2009 in Blood
Verified
Journal Article
Open access
PDF file
EREmanuela Rosati
Emanuela Rosati
RSRita Sabatini
Rita Sabatini
GRGiuliana Rampino
Giuliana Rampino
ATAntonio Tabilio
Antonio Tabilio
MIMauro Di Ianni
Mauro Di Ianni
PMPierfrancesco Marconi
Pierfrancesco Marconi
Notch signaling is involved in tumorigenesis, but its role in B–chronic lymphocytic leukemia (B-CLL) pathogenesis is not completely defined. This study examined the expression and activation of Notch receptors in B-CLL cells and the role of Notch signaling in sustaining the survival of these cells. Our results show that B-CLL cells but not normal B cells constitutively express Notch1 and Notch2 proteins as well as their ligands Jagged1 and Jagged2. Notch signaling is constitutively activated in B-CLL cells, and its activation is further increased in B-CLL cells, which resist spontaneous apoptosis after 24-hour ex vivo culture. Notch stimulation by a soluble Jagged1 ligand increases B-CLL cell survival and is accompanied by increased nuclear factor–kappa B (NF-κB) activity and cellular inhibitor of apoptosis protein 2 (c-IAP2) and X-linked inhibitor of apoptosis protein (XIAP) expression. In contrast, Notch-signaling inhibition by the γ-secretase inhibitor I (GSI; z-Leu-Leu-Nle-CHO) and the specific Notch2 down-regulation by small-interfering RNA accelerate spontaneous B-CLL cell apoptosis. Apoptotic activity of GSI is accompanied by reduction of NF-κB activity and c-IAP2 and XIAP expression. Overall, our findings show that Notch signaling plays a critical role in B-CLL cell survival and apoptosis resistance and suggest that it could be a novel potential therapeutic target.

1 March 2018 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
LMLorella Marinucci
Lorella Marinucci
SBStefania Balloni
Stefania Balloni
KFKatia Fettucciari
Katia Fettucciari
MBMaria Bodo
Maria Bodo
VTVincenzo N. Talesa
Vincenzo N. Talesa
Cinzia AntognelliCinzia Antognelli
Cinzia Antognelli

1 January 1998 in Immunology
Verified
Journal Article
Open access
PDF file
PCP Cornacchione
P Cornacchione
LSL Scaringi
L Scaringi
KFKatia Fettucciari
Katia Fettucciari
EREmanuela Rosati
Emanuela Rosati
RSR Sabatini
R Sabatini
PMP Marconi
P Marconi
Group B streptococci (GBS) are an important cause of neonatal sepsis, pneumonia and meningitis. In the early phase of infection, macrophages and polymorphonuclear cells (PMN) are the first immune cells that interact with GBS. In this in vitro study, to gain insight into GBS–macrophage interaction in the absence of type‐specific antibodies, we examined the features of GBS survival in thioglycollate‐elicited murine peritoneal macrophages and the effect of GBS on the protein kinase C (PKC)‐dependent transduction pathway. Our results demonstrate that type Ia GBS, strain 090 (GBS‐Ia) and type III GBS strain COH 31r/s (GBS‐III), after in vitro phagocytosis survive and persist intracellularly in macrophages for up to 24 and 48 hr, respectively. However, macrophage activation by interferon‐γ (IFN‐γ) and lipopolysaccharide from Escherichia coli (LPS) caused a significant reduction in the time of intracellular persistence. Macrophage activation by IFN‐γ and LPS seems to be a multifactorial event involving multiple intracellular signal pathways also including PKC. Since PKC is one of the components in the signal network leading to macrophage activation and an important target for several intracellular micro‐organisms, we wondered whether PKC could have a role in intracellular GBS survival. Both PKC depletion by treatment with phorbol 12‐myristate 13‐acetate (PMA) for 18 hr and PKC inhibition by Calphostin C rendered macrophages more permissive for the intracellular GBS survival. Furthermore, GBS‐infected macrophages were unable to respond to PMA and LPS, activators of PKC, by inducing antimicrobial activity. The ability of GBS to impair PKC‐dependent cell signalling was also demonstrated by the reduced c‐fos gene expression in GBS‐infected macrophages with respect to control macrophages, after LPS stimulation. In conclusion, our results indicate that GBS survive in macrophages and impairment of PKC signal transduction contributes to their intracellular survival.

14 October 2010 in Blood
Verified
Journal Article
Closed access
PDF file
EREmanuela Rosati
Emanuela Rosati
RSRita Sabatini
Rita Sabatini
GRGiuliana Rampino
Giuliana Rampino
FFFilomena De Falco
Filomena De Falco
MIMauro Di Ianni
Mauro Di Ianni
PMPierfrancesco Marconi
Pierfrancesco Marconi
A better understanding of apoptotic signaling in B-chronic lymphocytic leukemia (B-CLL) cells may help to define new therapeutic strategies. This study investigated endoplasmic reticulum (ER) stress signaling in spontaneous apoptosis of B-CLL cells and whether manipulating ER stress increases their apoptosis. Results show that a novel ER stress-triggered caspase cascade, initiated by caspase-4 and involving caspase-8 and -3, plays an important role in spontaneous B-CLL cell apoptosis. ER stress-induced apoptosis in B-CLL cells also involves CHOP/GADD153 up-regulation, increased JNK1/2 phosphorylation, and caspase-8–mediated cleavage of Bap31 to Bap20, known to propagate apoptotic signals from ER to mitochondria. In ex vivo B-CLL cells, some apoptotic events associated with mitochondrial pathway also occur, including mitochondrial cytochrome c release and caspase-9 processing. However, pharmacologic inhibition studies show that caspase-9 plays a minor role in B-CLL cell apoptosis. ER stress also triggers survival signals in B-CLL cells by increasing BiP/GRP78 expression. Manipulating ER signaling by siRNA down-regulation of BiP/GRP78 or treating B-CLL cells with 2 well-known ER stress-inducers, tunicamycin and thapsigargin, increases their apoptosis. Overall, our findings show that ER triggers an essential pathway for B-CLL cell apoptosis and suggest that genetic and pharmacologic manipulation of ER signaling could represent an important therapeutic strategy.

17 November 2012 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
BPBeatrice Del Papa
Beatrice Del Papa
PSPaolo Sportoletti
Paolo Sportoletti
DCDebora Cecchini
Debora Cecchini
EREmanuela Rosati
Emanuela Rosati
CBChiara Balucani
Chiara Balucani
MIMauro Di Ianni
Mauro Di Ianni
Notch1 signaling is involved in regulatory T (Treg)‐cell differentiation. We previously demonstrated that, when cocultured with CD3+ cells, mesenchymal stem cells (MSCs) induced a T‐cell population with a regulatory phenotype. Here, we investigated the molecular mechanism underlying MSC induction of human Treg cells. We show that the Notch1 pathway is activated in CD4+ T cells cocultured with MSCs. Inhibition of Notch1 signaling through GSI‐I or the Notch1 neutralizing antibody reduced expression of HES1 (the Notch1 downstream target) and the percentage of MSC‐induced CD4+CD25highFOXP3+ cells in vitro. Moreover, we demonstrate that FOXP3 is a downstream target of Notch signaling in human cells. No crosstalk between Notch1 and TGF‐β signaling pathways was observed in our experimental system. Together, these findings indicate that activation of the Notch1 pathway is a novel mechanism in the human Treg‐cell induction mediated by MSCs.

1 August 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
VCVeronica Ceccarelli
Veronica Ceccarelli
SRSerena Racanicchi
Serena Racanicchi
MMMaria Paola Martelli
Maria Paola Martelli
GNGiuseppe Nocentini
Giuseppe Nocentini
KFKatia Fettucciari
Katia Fettucciari
AVAlba Vecchini
Alba Vecchini
Polyunsaturated fatty acids (PUFAs) inhibit proliferation and induce differentiation in leukemia cells. To investigate the molecular mechanisms whereby fatty acids affect these processes, U937 leukemia cells were conditioned with stearic, oleic, linolenic, α-linolenic, arachidonic, eicosapentaenoic, and docosahexaenoic acids. PUFAs affected proliferation; eicosapentaenoic acid (EPA) was the most potent on cell cycle progression. EPA enhanced the expression of the myeloid lineage-specific transcription factors CCAAT/enhancer-binding proteins (C/EBPβ and C/EBPδ), PU.1, and c-Jun, resulting in increased expression of the monocyte lineage-specific target gene, the macrophage colony-stimulating factor receptor. Indeed, it is known that PU.1 and C/EBPs interact with their consensus sequences on a small DNA fragment of macrophage colony-stimulating factor receptor promoter, which is a determinant for expression. We demonstrated that C/EBPβ and C/EBPδ bind the same response element as a heterodimer. We focused on the enhanced expression of C/EBPδ, which has been reported to be a tumor suppressor gene silenced by promoter hypermethylation in U937 cells. After U937 conditioning with EPA and bisulfite sequencing of the −370/−20 CpG island on the C/EBPδ promoter region, we found a site-specific CpG demethylation that was a determinant for the binding activity of Sp1, an essential factor for C/EBPδ gene basal expression. Our results provide evidence for a new role of PUFAs in the regulation of gene expression. Moreover, we demonstrated for the first time that re-expression of the tumor suppressor C/EBPδ is controlled by the methylation state of a site-specific CpG dinucleotide.